HOLX's Enhanced Fibroid Treatment Portfolio Powers GYN Surgical Growth

Key Takeaways HOLX positions its GYN Surgical segment for strong growth with minimally invasive fibroid solutions.International efforts help Hologic drive consistent growth in minimally invasive surgical products.Gynesonics' acquisition strengthens Hologic's ability to treat mid-sized fibroids.Hologic (HOLX) continues to experience strong momentum across its GYN Surgical portfolio, underscoring the increasing global focus on women’s health. The company’s investments in commercial and market access capabilit ...